» Articles » PMID: 38851718

Radiation Pneumonitis Prediction with Dual-radiomics for Esophageal Cancer Underwent Radiotherapy

Overview
Journal Radiat Oncol
Publisher Biomed Central
Specialties Oncology
Radiology
Date 2024 Jun 8
PMID 38851718
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To integrate radiomics and dosiomics features from multiple regions in the radiation pneumonia (RP grade ≥ 2) prediction for esophageal cancer (EC) patients underwent radiotherapy (RT).

Methods: Total of 143 EC patients in the authors' hospital (training and internal validation: 70%:30%) and 32 EC patients from another hospital (external validation) underwent RT from 2015 to 2022 were retrospectively reviewed and analyzed. Patients were dichotomized as positive (RP+) or negative (RP-) according to CTCAE V5.0. Models with radiomics and dosiomics features extracted from single region of interest (ROI), multiple ROIs and combined models were constructed and evaluated. A nomogram integrating radiomics score (Rad_score), dosiomics score (Dos_score), clinical factors, dose-volume histogram (DVH) factors, and mean lung dose (MLD) was also constructed and validated.

Results: Models with Rad_score_Lung&Overlap and Dos_score_Lung&Overlap achieved a better area under curve (AUC) of 0.818 and 0.844 in the external validation in comparison with radiomics and dosiomics models with features extracted from single ROI. Combining four radiomics and dosiomics models using support vector machine (SVM) improved the AUC to 0.854 in the external validation. Nomogram integrating Rad_score, and Dos_score with clinical factors, DVH factors, and MLD further improved the RP prediction AUC to 0.937 and 0.912 in the internal and external validation, respectively.

Conclusion: CT-based RP prediction model integrating radiomics and dosiomics features from multiple ROIs outperformed those with features from a single ROI with increased reliability for EC patients who underwent RT.

Citing Articles

Delta-radiomics analysis based on magnetic resonance imaging to identify radiation proctitis in patients with cervical cancer after radiotherapy.

Xue J, Wu M, Zhang J, Yang J, Lv G, Qu B Front Oncol. 2025; 15:1523567.

PMID: 39944831 PMC: 11813761. DOI: 10.3389/fonc.2025.1523567.

References
1.
Hope A, Lindsay P, El Naqa I, Alaly J, Vicic M, Bradley J . Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys. 2006; 65(1):112-24. DOI: 10.1016/j.ijrobp.2005.11.046. View

2.
Lan K, Zhu J, Zhang J, Zhou S, Yang Y, Feng Z . Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy. Radiother Oncol. 2020; 149:228-235. DOI: 10.1016/j.radonc.2020.05.036. View

3.
Basch E, Reeve B, Mitchell S, Clauser S, Minasian L, Dueck A . Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014; 106(9). PMC: 4200059. DOI: 10.1093/jnci/dju244. View

4.
Zwanenburg A, Vallieres M, Abdalah M, Aerts H, Andrearczyk V, Apte A . The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. Radiology. 2020; 295(2):328-338. PMC: 7193906. DOI: 10.1148/radiol.2020191145. View

5.
Kawahara D, Imano N, Nishioka R, Ogawa K, Kimura T, Nakashima T . Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis. Sci Rep. 2021; 11(1):16232. PMC: 8355298. DOI: 10.1038/s41598-021-95643-x. View